Searching for new therapeutic options for the uncommon pathogen Mycobacterium chimaera: an open drug discovery approach.

Cantillon, Daire; Goff, Aaron; Taylor, Stuart; Salehi, Emad; Fidler, Katy; Stoneham, Simon; Waddell, Simon J

Cantillon, Daire; Goff, Aaron; Taylor, Stuart; Salehi, Emad; Fidler, Katy; Stoneham, Simon; Waddell, Simon J.

Afiliação

Cantillon D; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Falmer, UK.
Goff A; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Falmer, UK.
Taylor S; Department of Microbiology and Infection, Royal Sussex County Hospital, Brighton, UK.
Salehi E; School of Pharmacy, University of Sussex, Falmer, UK.
Fidler K; Clinical and Experimental Medicine, Brighton and Sussex Medical School, University of Sussex, Falmer, UK; Academic Department of Paediatrics, Royal Alexandra Children's Hospital, Brighton, UK.
Stoneham S; Department of Microbiology and Infection, Royal Sussex County Hospital, Brighton, UK.
Waddell SJ; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Falmer, UK. Electronic address: s.waddell@bsms.ac.uk.

Lancet Microbe ; 3(5): e382-e391, 2022 05.

Article em En | MEDLINE | ID: mdl-35544099

Assuntos

Anti-Infecciosos; Mycobacterium tuberculosis; Animais; Anti-Infecciosos/farmacologia; Doxiciclina/farmacologia; Descoberta de Drogas; Humanos; Mycobacterium; Complexo Mycobacterium avium

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Anti-Infecciosos / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Lancet Microbe Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google